Meininger David is listed as an executive officer, director, and promoter on 1 SEC Form D filing by 1 issuer in Apr 2021: Link Immunotherapeutics, Inc. (Seattle, WA — industry reported as "Other" — 2021; $14.3M reported sold to 9 investors).
What this means One deal on file with the SEC, filed Apr 2021. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Daniel O'Connell (1 shared filing), Edward van Wezel (1 shared filing) and Roger Ulrich (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Meininger. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Meininger David and found 1 difference: No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.